13F Data
13F filer · CIK 1816307

SILVERARC CAPITAL MANAGEMENT, LLC

BOSTON, MA · filing since Q4 2020 · last filing Aug 13, 2026
Reported value
$962.2M
$-17.7M vs prior
Positions
73
New / sold out
26 / 26
Added / reduced
17 / 27
Turnover
36.4%
buys $353.3M · sells $500.3M
Top-10 weight
42.3%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewASCENDIS PHARMA A/S+206,234–+$55.0M
NewENLIVEN THERAPEUTICS INC+489,382–+$24.8M
NewSAGIMET BIOSCIENCES INC+2,927,698–+$22.6M
NewARK ETF TRPUT+500,000–+$21.0M
AddedORUKA THERAPEUTICS INC+201,894+133.8%+$19.2M
NewDEFINIUM THERAPEUTICS INC+400,000–+$18.8M
AddedCELCUITY INC+143,093+40.0%+$15.0M
NewALX ONCOLOGY HLDGS INC+5,744,757–+$11.9M
NewVERADERMICS INC+95,000–+$11.7M
NewAVALYN PHARMACEUTICALS INC+330,487–+$10.9M
33 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outSPDR SERIES TRUSTPUT-825,000-100.0%$-105.4M
Sold outKALVISTA PHARMACEUTICALS INC-2,876,407-100.0%$-57.9M
Sold outNUVALENT INC-354,914-100.0%$-36.4M
Sold outASCENDIS PHARMA A/S-124,658-100.0%$-28.5M
ReducedDIANTHUS THERAPEUTICS INC-264,746-40.4%$-25.8M
ReducedMONTE ROSA THERAPEUTICS INC-893,745-44.6%$-21.6M
Sold outCENTESSA PHARMACEUTICALS PLC-466,345-100.0%$-18.5M
ReducedALKERMES PLC-346,820-75.3%$-18.2M
ReducedABIVAX SA-132,937-43.9%$-17.7M
ReducedKODIAK SCIENCES INC-445,674-44.9%$-17.4M
43 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2020: $172.1MQ1 2021: $183.3MQ2 2021: $211.6MQ3 2021: $176.9MQ4 2021: $246.8MQ1 2022: $214.8MQ2 2022: $324.8MQ3 2022: $295.6MQ4 2022: $349.6MQ1 2023: $242.3MQ2 2023: $323.3MQ3 2023: $329.8MQ4 2023: $336.0MQ1 2024: $360.1MQ2 2024: $423.9MQ3 2024: $445.3MQ4 2024: $457.2MQ1 2025: $489.0MQ2 2025: $542.3MQ3 2025: $741.6MQ4 2025: $720.1MQ1 2026: $979.8MQ2 2026: $962.2M
Q4 2020Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1ASCENDIS PHARMA A/SORD SHS206,234$55.0M5.72%
2CELCUITY INCCOM500,996$52.4M5.45%
3COGENT BIOSCIENCES INCCOM1,280,707$49.6M5.15%
4UROGEN PHARMA LTDCOM1,301,979$47.9M4.98%
5IMMUNOME INCCOM2,017,009$42.7M4.44%
6DIANTHUS THERAPEUTICS INCCOM390,000$38.0M3.95%
7RHYTHM PHARMACEUTICALS INCCOM311,461$34.6M3.59%
8ORUKA THERAPEUTICS INCCOM352,802$33.6M3.49%
9MONTE ROSA THERAPEUTICS INCCOM1,108,295$26.8M2.79%
10SYNDAX PHARMACEUTICALS INCCOM1,214,390$26.5M2.76%
63 more rows. Subscribe for $29/month to see every row, download the data and use the API.